Ken Fisher's position in Regeneron Pharmaceuticals is currently worth $5.04 Million. That's 0.00% of their equity portfolio (474th largest holding). The first Regeneron Pharmaceuticals trade was made in Q3 2014. Since then Ken Fisher bought shares eighteen more times and sold shares on eighteen occasions. The stake costed the investor $2.73 Million, netting the investor a gain of 85% so far.